Research & Education
CURE Expert Connections
Email Sign Up
To start your customized experience click the start button
Customize your homepage by selecting specific cancer types.
Cancer of Unknown Primary
Diet and Exercise
Gastrointestinal stromal tumor
General Financial Topics
General Psychosocial Aspect Topics
Head & Neck Cancer
Mantle Cell Lymphoma
Metastatic Breast Cancer
Side Effect Management
Small Lymphocytic Lymphoma (SLL)
Advocacy & Research
Share Your Story
Newsletter Sign Up
Ovarian Cancer Heroes
Bone Health Champions
Terms & Conditions
Cure Media Group, LLC.
2 Clarke Drive
Cranbury, NJ 08512
Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Mantle Cell Lymphoma
Expert Weighs In on What's Next for Mantle Cell Lymphoma
The treatment landscape of mantle cell lymphoma is continuing to change. See what expert Andre Goy, M.D., has to say about it.
FDA Approves Drug for Chronic Immune Thrombocytopenia
Tavalisse (fostamatinib) was granted approval by the Food and Drug Administration (FDA) for patients with chronic immune thrombocytopenia (ITP) after they had an insufficiencent response to another therapy.
Guilt Is Good, Says One Cancer Survivor
Kevin unleashes his inner guilt for the benefit of you, gentle readers.
You Know You've Been to the Oncologist Too Many Times When...
You walk in and the entire staff yells your name, al la “Norm” of Cheers fame
Exploring Genetic Testing for Mantle Cell Lymphoma
Grzegorz S. Nowakowski, M.D., discusses the potential for genetic testing for patients with mantle cell lymphoma.
Run Cancer Run
A non-runner explains why running and cancer are the same thing. Except they're not.
Combinations Are Showing Promise in MCL
Andre Goy, M.D., discusses some exciting advances in mantle cell lymphoma (MCL).
The Lighter Side Of Cancer
In this episode of Cancer With Kevin, we explore the unexpected humor that comes with the general awfulness
The Business Of Cancer
Cancer quickly becomes your new, unwelcome, family business
Exploring Combinations in Mantle Cell Lymphoma
Adding Ibrance to Imbruvica may be a promising treatment strategy for patients with mantle cell lymphoma, according to a recent study.
Not a member?
Sign up now!
Continue without login
OPTIONAL INFORMATION: The following information helps us tailor CURE to fit your needs
Please type below what best describes your interests and click on the selection(s):
I am a:
Please list other: